[NASDAQ:ZOLL] ZOLL MEDICAL CORPORATION > 27.67
ZOLL Medical Corporation designs, manufactures, markets, and sells non-invasive resuscitation devices and related software solutions in the United States and internationally. Its products include pacing, defibrillation, circulation, ventilation, and fluid resuscitation devices that enable clinicians, emergency medical services (EMS) professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. The company's resuscitation line of products include professional defibrillators, which include M Series, E Series, R Series, and LifeVest wearable defibrillators; automated external defibrillators (AEDs) that assist with manual CPR efforts, which include the AED Pro and the AED Plus; disposable electrodes used with ZOLL's line of defibrillators; the AutoPulse automated chest compression systems, used to automate the process of delivering chest compressions; documentation and information management products, including RescueNet for EMS and fire personnel and CodeNet for hospitals; device and technology designed for endovascular hypothermia; and the ZOLL Infuser for fluid replacement.
-----------
Message 23887103 |
